Journals in Pharmaceutical sciences

1-10 of 44 results in All results

Journal of Pharmaceutical Sciences

ISSN: 0022-3549
5 Year impact factor: 3.7
Impact factor: 3.8

Journal of Pharmaceutical Sciences (www.jpharmsci.org) Access here additional scientific content published in the Journal of Pharmaceutical Sciences including: "freely available" Dedicated Issues to "Giants in the Pharmaceutical Sciences"; "freely available" Special Issue on Pharmaceutical Biotechnology; "freely available" Virtual Issues on Featured Papers, Ebert Prize papers, Biowaiver Monographs, 10 Most Downloaded Papers in 2015, 10 Most Cited Papers in 2015 and Editors' Choices of the Papers containing the Most Original and Most Significant Scientific Findings; other Virtual Issues on Clinical Trials and Translational Medicine Commentaries, Special Topic Commentaries, Global Health papers, and Lessons Learned; and a Drug Delivery Clinical Trials Database. The Journal of Pharmaceutical Sciences will publish original research papers, original research notes, invited topical reviews (including Minireviews), and editorial commentary and news. The area of focus shall be concepts in basic pharmaceutical science and such topics as chemical processing of pharmaceuticals, including crystallization, lyophilization, chemical stability of drugs, pharmacokinetics, biopharmaceutics, pharmacodynamics, pro-drug developments, metabolic disposition of bioactive agents, dosage form design, protein-peptide chemistry and biotechnology specifically as these relate to pharmaceutical technology, and targeted drug delivery.

Therapies

ISSN: 0040-5957
5 Year impact factor: 2.1
Impact factor: 2.6

Official publication of the Société Française de Pharmacologie et de Thérapeutique (SFPT) – Organe officiel de la Société Française de Pharmacologie et de Thérapeutique (SFPT) Therapies is a peer-reviewed journal devoted to Clinical Pharmacology, Therapeutics, Pharmacokinetics, Pharmacovigilance, Addictovigilance, Social Pharmacology, Pharmacoepidemiology, Pharmacoeconomics and Evidence-Based-Medicine. Thérapie publishes in French or in English original articles, general reviews, letters to the editor reporting original findings, correspondence relating to articles or letters published in the Journal, short articles, editorials on up-to-date topics, Pharmacovigilance or Addictovigilance reports that follow the French "guidelines" concerning good practice in pharmacovigilance publications. The journal also publishes thematic issues on topical subject. The journal is indexed in the main international data bases and notably in: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index. Thérapies est un journal bimensuel consacré à des sujets de pharmacologie clinique, de thérapeutique, de pharmacocinétique, de pharmacovigilance, d'addictovigilance, de pharmacologie sociale, de pharmacoépidémiologie, de pharmacoéconomie ou de médecine factuelle. La revue publie en langue française ou anglaise des mémoires originaux, des revues générales, des lettres à la rédaction exposant des faits originaux, des correspondances à propos d'articles ou de lettres publiés dans la revue, des observations de pharmacovigilance et d'addictovigilance répondant aux normes des bonnes pratiques de publication. Elle propose également des comptes rendus et actes de congrès, et des numéros à thème en rapport avec l'actualité. Thérapies est indexé dans les principales bases de données biomédicales: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index.

Revista Brasileira de Farmacognosia

ISSN: 0102-695X

Revista Brasileira de Farmacognosia will be transferred back to the Brazilian Society of Pharmacognosy, as of January 2020 and the journal is no longer receiving new submissions via EVISE. New submissions are welcomed at: https://www.editorialmanager.com/rbfa/default.aspx The Brazilian Journal of Pharmacognosy is a scientific journal edited and published by the Brazilian Society of Pharmacognosy, an association that brings together researchers, students and professionals who study and investigate the physical, chemical and biological drugs, especially those of vegetable origin, substances isolated and such as the potential source of drugs of natural origin. It is available in printed form for its members and subscribers and openly on the Internet in all your numbers and content. The articles published are original research contributions. To evaluate the work use is made of international standards and is held by the ad hoc advisers, which reflects the quality and credibility of the journal. The BJP is published since 1986. The Brazilian Journal of Pharmacognosy is an instrument for disseminating the results of research projects developed primarily by Brazilian scientists, giving visibility to scientific contributions in the field of pharmacognosy (essentially works that deal with the botanical characterization of medicinal plant species, research and studies of active substances biological activity of extracts and isolated compounds from plant species). The BJP also receives and publishes articles from foreign researchers who also contribute to the dissemination of the pharmacognosy from their countries of origin. The journal's mission is to be an important channel and broad dissemination of scientific researchers and post-graduate programs. For this, the Brazilian Society of Pharmacognosy makes all efforts to maintain regularity and credibility of its journal.

Journal of Controlled Release

ISSN: 0168-3659
5 Year impact factor: 10.2
Impact factor: 10.8

The Journal of Controlled Release (JCR) is the Official Journal of the Controlled Release Society, and of the Japan Society of Drug Delivery System. It publishes high-quality research articles in the broad field of delivery science and technology. This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Manuscripts that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority.

Advanced Drug Delivery Reviews

ISSN: 0169-409X
5 Year impact factor: 17.7
Impact factor: 16.1

The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery. In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues. Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution. Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

World Patent Information

ISSN: 0172-2190
5 Year impact factor: 2.4
Impact factor: 2.7

The journal for intellectual property information and its retrieval, documentation, classification, search, analysis and IP management World Patent Information aims to encompass the world of IP information; and focus the journal towards IPRs for industrially applicable innovations; and their management, analysis; big data analysis; policy; education. IPRs - patents, utility models; copyright, trademarks, registered design; design rights; trade secrets; database rights; traditional knowledge; indigenous knowledge; geographical indications may all be considered. World Patent Information publishes articles regarding best practice in legal and commercial patent search and analysis; articles which focus on particular types of search such as freedom to operate, FTO, clearance, state of the art, invalidity, validity, prior art, technical, landscaping, scouting, forecasting, patentability, decision searching, competitive intelligence using patent information. We are also interested in articles researching into meta data relating to IPRs such as legal status data for IPR; classifications and bibliographic data. We are interested in IP documentation, search, documentation, classification and IP information news from IP Offices. Always welcome are reviews of state of the art in a particular industry, reviews of patent, and other IP and scientific and technical databases, search and analysis for IP purposes. Research and review articles on information related to non- patent IPRs , trademarks, trade names, brands, designs, copyright, trade secrets, traditional knowledge, semiconductor rights, database rights, where these have impact for the technological innovation space. Best practice search and review articles, on sources of data. IP management information issues, inventions harvesting, IP services and intermediates and use of text mining and data mining for IP interests. Information retrieval (IR) relating to all aspects of IP published information not only text but also document specific, e.g. bibliographic, name, geographic; multi-lingual search, image search, tables, other non-text; text mining, Natural Language Processing (NLP); Information Extraction from patents e.g. – mathematical formulae, chemical, biological, plant, related data; Machine Translation, Machine learning, automated intelligence focused towards improving IP search and analysis; System Evaluation and Benchmarking, Data collections for IR experiments; Best practice for IP; IP management of Patents, Trademarks,. designs, know-how, copyright, trade secrets; organization of IP tasks in companies and research institutions; Innovation management -impact of patent and IP management; information management for IP best practice, TRIZ and its implementation for innovation processes; Technology management –characteristics and dynamics of technologies in IP perspective, IP portfolio benchmarking, valuation, geographic, expiries, technological, Advanced analysis –market, corporate, policy level, statistical analysis, Business methods patenting, Standards - standard essential patents – patent pools.

Nigerian Journal of Pharmaceutical Sciences

ISSN: 0189-322X

AIM OF THE JOURNAL To create a platform for the dissemination and communication of the ever growing changes and development in the field of Pharmacy practice. SCOPE OF THE JOURNAL The journal is devoted to publishing original research works in all the branches of Pharmacy, including (but not restricted to) Pharmaceutics, Pharmaceutical Chemistry, Pharmacology, Pharmacognosy, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Clinical Pharmacy, Industrial Pharmacy Toxicology, Phytochemistry, Traditional Medicine, Medicinal Chemistry, Ethno-botany etc.

Nigerian Journal of Pharmaceutical Sciences

Fitoterapia

ISSN: 0367-326X
5 Year impact factor: 3.3
Impact factor: 3.4

The Journal for the Study of Medicinal Plants Fitoterapia is a Journal dedicated to medicinal plants and fungi and to the bioactive natural products produced by these organisms. It publishes original contributions in seven major areas: 1. Chemical characterization of active ingredients of medicinal plants and fungi, including their endophytes 2. New analytical approaches for dereplication and standardization of biologically active extracts and metabolites from plant resources 3. Identification of bioactivity in plant and fungal extracts and in their constituents 4. Identification of biological targets and mechanism of activity of plant and fungal extracts 5. Production and genomic characterization of medicinal plants biomass 6. Biosynthesis of bioactive natural products of plant, fungi and endophytic origin 7. Critical reviews of the composition, history, clinical and legal status of medicinal plants, and accounts on topical issues. Contributions reporting the following are NOT normally considered for publication: 1. Activity data on crude extracts that have not been characterized by analysis of their major constituents (HPLC fingerprint, LC/MS or NMR). Data on the extract composition simply taken from the literature are not acceptable. Characterization of only a few constituents is generally considered too partial. 2. Studies on the bioactivity of pure compounds purchased or obtained by Authors without any study or relationship with the producing organism. 3. Unexceptional and predictable bioactivity (e.g. antioxidant properties of phenolics or antibacterial activity of essential oils). 4. Uncritical ethnopharmacological investigations, where a list of plants and their use are simply recorded. 5. Genomic, transcriptomic and pharmacological studies without convincing wet lab experiments, or with little correlation to bioactive natural compounds. In addition, the following immediate rejection criteria apply: RULE 1: The manuscript does not fall into any of the areas of interest of the Journal. RULE 2: The manuscript is too preliminary, reporting e.g. activity data without comparison to a reference, or without a positive control. RULE 3: The botanical source is not clearly identified, authenticated, and documented (voucher). RULE 4: Characterization of new compounds without spectral supporting material. RULE 5: Bioactivity is not relevant to in vivo situations. RULE 6: Reviews on topics already covered in the recent literature.

International Journal of Pharmaceutics

ISSN: 0378-5173
5 Year impact factor: 5.8
Impact factor: 5.8

The International Journal of Pharmaceutics has an open access companion journal International Journal of Pharmaceutics: X which has the same aims and scope and peer-review process. To submit to International Journal of Pharmaceutics: X visit https://www.editorialmanager.com/IJPHARMX/default.aspx. The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues. Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher. Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.

Journal of Ethnopharmacology

ISSN: 0378-8741
5 Year impact factor: 5.3
Impact factor: 5.4

The Journal of Ethnopharmacology is the Official Journal of the International Society for Ethnopharmacology. The journal is dedicated to the exchange of information and understandings about people's use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions. The Journal of Ethnopharmacology publishes original articles concerned with the observation and experimental investigation of the biological activities of plant and animal substances used in the traditional medicine of past and present cultures, which document indigenous medical knowledge, study indigenous medicines in order to contribute in the long-run to improved health care in the regions of study, and which report on pharmacologically unique principles from existing indigenous remedies. The journal will particularly welcome interdisciplinary papers with an ethnopharmacological, an ethnobotanical or an ethnochemical approach to the study of indigenous drugs. It is imperative that experimental studies are aligned and related to the traditional use(s). Furthermore: Reports of anthropological and ethnobotanical field studies fall within the journal's scope. Studies involving pharmacological and toxicological mechanisms of action are especially welcome. Clinical studies on efficacy will be considered if contributing to the understanding of specific ethnopharmacological problems. The journal welcomes review articles in the above-mentioned fields especially those highlighting the multi-disciplinary nature of ethnopharmacology.